Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia-Reference-Cited by-同舟云学术

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia

Published:2018-02-23 Issue:7 Volume:32 Page:1598-1608
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Rothenberg-Thurley Maja,Amler Susanne,Goerlich Dennis,Köhnke Thomas,Konstandin Nikola P.,Schneider Stephanie,Sauerland Maria C.,Herold Tobias,Hubmann Max,Ksienzyk Bianka,Zellmeier Evelyn,Bohlander Stefan K.^ORCID,Subklewe Marion,Faldum Andreas,Hiddemann Wolfgang,Braess Jan,Spiekermann Karsten,Metzeler Klaus H.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0034-z.pdf

Reference33 articles.

1. Jan M, Snyder TM, Corces-Zimmerman MR, Vyas P, Weissman IL, Quake SR, et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med. 2012;4:149ra118.

2. Corces-Zimmerman MR, Hong W-J, Weissman IL, Medeiros BC, Majeti R. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci USA. 2014;111:2548–53.

3. Shlush LI, Zandi S, Mitchell A, Chen WC, Brandwein JM, Gupta V, et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature. 2014;506:328–33.

4. Hirsch P, Zhang Y, Tang R, Joulin V, Boutroux H, Pronier E, et al. Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia. Nat Commun. 2016;7:12475.

5. Hirsch P, Tang R, Abermil N, Flandrin P, Moatti H, Favale F, et al. Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia. Haematologica. 2017;102:1227–37.

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges;Frontiers in Immunology;2024-06-13

2. Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study;Blood Cancer Journal;2024-06-13

3. Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia;Cell Death & Disease;2024-06-12

4. ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study;Targeted Oncology;2024-04-29

5. Convergent epigenetic evolution drives relapse in acute myeloid leukemia;eLife;2024-04-22